© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Potassium antimonyl tartrate hemihydrate has roots stretching back before antibiotics and advanced blood testing defined modern medicine. Doctors in the 19th century prescribed it under the name tartar emetic for treating everything from fever to parasitic infections, sometimes as a tool to induce vomiting. Hospitals and field physicians saw it as a workhorse during outbreaks of schistosomiasis and leishmaniasis. Many learned through trial and error about the narrow gap between an effective dose and a toxic one. Medical schools and early industrial chemists saw this substance as evidence of a time when observation and raw experimentation guided drug development. Over the decades, research journals tracked its rise, peak, and steady decline as less hazardous alternatives arrived. Its story reflects a medical era built more on courage and urgency than today’s rigorous understanding of molecular actions and side effects.
Potassium antimonyl tartrate hemihydrate presents as a white, odorless crystalline powder. The chemical features both potassium and antimony atoms coordinated within an organic tartrate framework. Drug manufacturers and chemical labs catalogue it by several names: tartar emetic, potassium antimony tartrate, and antimonium tartaricum. The compound is water-soluble and, before better medicines emerged, found wide use as a treatment for tropical diseases and a laboratory reagent. For a long time, hospitals stocked tartar emetic as a go-to for parasitic infections, and its inclusion in the World Health Organization’s Model List of Essential Medicines underscores a practical role far beyond niche research.
Each dose of potassium antimonyl tartrate hemihydrate embodies the complex chemistry of antimony. As a hydrate, the powder attracts and holds water, changing slightly as humidity shifts. It melts with decomposition starting at around 240°C. Chemistry handbooks describe its clear solubility in water and sharp utility in diagnostic titrations. Its formula, K(SbO)C4H4O6 · ½H2O, makes it a double salt featuring both antimony(V) and potassium. In sunlight or heat, the material's structure can degrade, so careful storage matters. This predictability made it practical for use in medical, educational, and industrial contexts, but also highlights risks, as antimony compounds do not tolerate careless handling.
Technical documentation for this chemical reads like a warning fused with a guidebook. Labels must show the IUPAC name, CAS number, molecular weight, purity levels, and the content of antimony, potassium, and tartrate ions. Even small differences in water content can shift the microbalance in sensitive lab setups, so high-precision analytics become necessary. Most companies set purity levels at 98% or better; packaging calls for moisture-proof containers and clear hazard communications. UN shipping codes and GHS safety labels remain non-negotiable to ensure proper handling. Chemists learn quickly that ignoring those details leads to frustration at best and danger at worst.
Synthesis usually starts with tartaric acid—often a by-product from winemaking. Potassium carbonate neutralizes the acid, forming potassium tartrate. Chemists then add antimony trioxide in water under careful stirring, watching as it reacts to produce the desired double salt. Filtration and slow evaporation give crystalline potassium antimonyl tartrate hemihydrate. Only by following strict temperature controls and precise stoichiometry does the final product reach high purity and prompt regulatory approval. In research labs, even a single misstep in this process can leave behind toxic impure by-products, highlighting the skills that no machine alone can replace, especially during scale-up production.
This compound finds its main chemical activity in reactions based on its antimony(V) core. It reacts with acids to evolve toxic antimony gas, which makes lab safety protocols essential. Chemists have modified its tartrate backbone and antimony coordination environment to explore treatments with altered toxicity or improved uptake. In some studies, substituting other alkali metals captures subtle differences in reactivity. Not every experiment led to commercial breakthroughs, but each attempt revealed more about antimony’s pharmacological quirks. Modern researchers continue to probe these nuances, hoping to unlock new molecules that heal without harming.
Potassium antimonyl tartrate hemihydrate exists by more names than most realize: tartar emetic, potassium antimony tartrate, antimonyl potassium tartrate, and antimonium tartaricum. In hospital settings and classical pharmacopoeias, “tartar emetic” sticks in the collective memory. In chemical catalogues, digital libraries, and safety manuals, the more technical names guide procurement and research. This complexity in naming has led to confusion in supply chain management and in regulatory filings. A clear understanding of all product aliases supports safer handling and regulatory compliance—often the difference between safe delivery and hazardous mix-ups.
Antimony compounds draw a hard line on lab and workplace safety. Even low exposure levels can cause nausea, vomiting, and, with higher amounts, heart and liver damage. Staff must use gloves, eye protection, and laboratory ventilation, following written risk assessments at all steps. Maintenance teams install chemical showers and eyewashes as standard equipment. Regulations like the OSHA Hazard Communication Standard and REACH in Europe classify the substance as hazardous, mandating training and recordkeeping. Disposal protocols require attention: wastewater pretreatment and controlled incineration prohibit shortcuts that could threaten public health or the environment. Hospitals and labs who skipped these steps paid dearly in regulatory fines and reputational loss.
Historically, doctors relied on this compound for its ability to trigger vomiting, reduce fever, and treat certain parasites. Over time, its primary use shifted toward veterinary medicine, specific diagnostic chemistry applications, and historical research into tropical disease treatments. In analytical laboratories, potassium antimonyl tartrate hemihydrate enables redox titrations and serves as a reference compound. Advanced researchers continue to use it as a precursor in developing new antimony-based drugs. Parallel industries, such as rare metal analysis and specialized glass production, still maintain technical protocols involving this compound. Shifting medical priorities and aggressive toxicity research have sharply reduced demand, but interest persists among historians and pharmaceutical scientists delving into the roots of neglected diseases.
Scholars studying neglected tropical diseases keep potassium antimonyl tartrate alive in academic journals. Several PhD dissertations over the past two decades focused on modifying its molecular structure to keep efficacy while shedding harmful effects. Medical chemists track antimony’s behavior in biological systems, which continues to teach lessons applicable to next-generation drug development. In the search for safer alternatives, grant-fueled research groups in endemic regions test new delivery methods and derivatives—hoping to solve the old puzzle of selective toxicity. Collaborations between chemistry and pharmacology departments fuel innovations where the lessons of tartar emetic blend with the promises of molecular engineering. As antibiotic resistance looms and interest in ancient remedies returns, the scientific world keeps potassium antimonyl tartrate in its collective mind, not as a front-line drug, but as a valuable reference in the struggle against persistent disease.
Modern safety protocols come from decades of painful human and animal case reports. Doctors once had little choice but to risk permanent injury or death to treat life-threatening infections like leishmaniasis. Researchers in the past 40 years documented permanent organ damage at doses only twice as high as the therapeutic minimum. Laboratory experiments show antimony builds up in the liver, lungs, and heart, causing serious risk if dosing remains uncontrolled. Toxicologists evaluate genetic, environmental, and nutritional factors that affect individual sensitivity—recognizing that one person’s cure becomes another’s misfortune. Their work informed new international standards that now shape screening, handling, and disposal requirements. Such caution arose from hard lessons; a single misstep exposed generations to irreversible harm. This history sits behind every modern restriction and safety manual, making it impossible to separate the chemical’s utility from its risks.
Research communities remain torn about the future role of potassium antimonyl tartrate hemihydrate. On the one hand, the chemical’s legacy in neglected tropical disease pushes some to look for safer methods to deliver its powerful effects. Advances in drug encapsulation, targeted delivery, and metabolic engineering could return antimony-based drugs to the arsenal, but only with firm safety improvements. Regulatory pressure and green chemistry push industry toward non-antimony-based alternatives. Scientists look at the existing molecule as a template for better agents: lower dose, reduced accumulation, or completely different scaffolding. Graduate-level pharmaceutical design courses often use potassium antimonyl tartrate as a case study in balancing efficacy with risk. As the chemical world matures, its story offers a blueprint for evolving hazardous medicines into life-saving, modern therapeutics that owe their existence to radical invention and equally radical caution. The next era relies on the willingness of research teams to learn from a compound whose lessons were often written in pain but always pointed toward hope.
Potassium antimonyl tartrate hemihydrate rarely pops up in conversation outside specialized fields, but the impact of this compound reaches both historical and modern medicine. Centuries ago, it carried a dramatic nickname—tartar emetic—because of its role in causing vomiting. Physicians used it to purge toxins from the body long before safer options arrived. At that time, people viewed vomiting as a logical response to poisoning, but also as a general cure for various illnesses. This approach feels wild by current standards, yet it shows how health practices have evolved with a better grasp of chemistry and safety.
Today, the landscape for potassium antimonyl tartrate hemihydrate has shifted. Doctors now look to this compound as part of specific treatments, mainly against a tropical parasitic disease called leishmaniasis. Leishmaniasis doesn’t make headline news in North America or Europe, but its pain and disfigurement trouble millions in South America, Africa, and parts of Asia. The drug’s antimony content attacks the parasites’ metabolism, slowing or stopping the infection. Even with its effectiveness, doctors only choose this drug when safer and more modern options cannot handle the infection. It’s no secret: the side effects can be harsh, so weighing risks and benefits becomes the main concern.
Some chemists use it for laboratory testing, particularly in confirming the presence of antimony. A few generations ago, the textile and leather industries benefited from its ability to fix dyes and tan leather, though environmental awareness and new technology have led to a steep decline in industrial applications. The compound doesn’t appear much in consumer goods today, given concerns about toxicity. Any lingering industrial use comes with careful handling and safety checks.
Potassium antimonyl tartrate hemihydrate can’t hide its reputation for toxicity. People exposed to it without enough protection—especially over long periods—suffer serious health consequences. Symptoms like headaches, nausea, and muscle aches point to poisoning. In high doses, it can even threaten life. These facts press professionals in both the medical and research fields to train staff thoroughly, limit unnecessary exposure, and follow strong protocols. Safer replacements do exist for most purposes, and that’s become the common choice where possible.
The old ways relied on this substance because options were thin. Now, modern treatments for diseases like leishmaniasis are in the pipeline, aiming for fewer side effects and better results. Investment in research pays off when new molecules surpass old ones in safety and effectiveness. For labs and production, automation and stricter regulations help reduce accidents, while training programs keep everyone sharp. At every level, progress depends on learning from the past and respecting both the power and the danger in these chemicals. Making smart choices isn’t just about following rules—it's about looking out for each other and the next generation who will inherit both the problems and the solutions we set in motion today.
Potassium Antimonyl Tartrate Hemihydrate comes with the formula K(SbO)C4H4O6·½H2O. Nobody uses this name to start a conversation, but the compound carries a long history linked to both science and medicine. For those of us who spent some time in a chemistry lab, the formula carries familiar elements—potassium, antimony, tartrate—and a subtle reminder that tiny details in formulas often change how people use substances in real life.
Unpacking that formula shows more than just a mix of letters and numbers. K stands for potassium, which most folks know from bananas, though here it acts as a counter-ion. SbO represents antimonyl, based on antimony, which played a major role in medicine for centuries. C4H4O6 refers to the tartrate part—derived from tartaric acid, commonly found in grapes. The ½H2O on the end tells us the structure locks in half a molecule of water per molecule of compound, making it a hemihydrate. In practice, even that little bit of water can reshape a compound’s stability and the way it dissolves, which counts for a lot in both chemistry and pharmacy.
Once called “tartar emetic,” Potassium Antimonyl Tartrate’s hemihydrate form went straight into mainstream medical use for centuries. Physicians prescribed it to treat conditions like schistosomiasis and leishmaniasis. Some even used it as an emetic or to treat fever. Those treatments didn’t rely on guesswork; they relied on the unique nature of antimony in the compound, and the water molecule that helped with solubility. Modern research, including clinical studies, exposed both its effectiveness and the harsh toxic side effects, causing a steep drop in medical use.
Science keeps finding ways to refine what was once taken for granted. Detailed understanding of the chemical formula means researchers can make safer antimony-based drugs or entirely new compounds with fewer side effects. The formula serves as a building block for making medical decisions and setting pharmaceutical guidelines. Toxicity studies published in reputable sources underscore the importance of clarity when it comes to chemical makeup—it only takes a small change in structure for effects on the body to change, too.
Students still see this compound in textbooks and laboratory manuals. Many chemistry teachers introduce the formula while discussing titrations or coordination compounds. Practical chemistry skills grow from hands-on experience with real compounds, and Potassium Antimonyl Tartrate has stood the test of time as a teaching tool. It challenges students to notice the interplay between a compound’s formula and its function.
Fact remains, Potassium Antimonyl Tartrate Hemihydrate is toxic. Regulatory agencies issue clear guidance about handling and disposal, and labs keep it behind lock and key. As science grows, it offers safer alternatives, and ongoing studies on chemical analogs aim to replace it in both education and industry without sacrificing reliability.
Understanding the formula—K(SbO)C4H4O6·½H2O—shapes choices in the lab, pharmacy, and classroom. Knowing it from textbooks means linking history, research, and safe practice. This kind of knowledge keeps science grounded in real-world care, encouraging a steady push for smarter and safer chemistry.
Potassium antimonyl tartrate hemihydrate isn’t a staple in household cupboards, but chemists and lab workers know it well. For some, it’s a reagent in labs or a remnant from the days when medicine tried almost anything on a patient. This compound blends antimony and tartaric acid, forming a powder that doesn’t make headlines like mercury, but still raises some eyebrows around safety.
Digging into its history, potassium antimonyl tartrate appeared in older treatments for parasitic diseases. The medical community moved away from it after safer and more effective drugs came along. It wasn’t just lack of progress or habit. The real issue: the risks outweigh potential benefits. Reports of poisoning and side effects mounted. Lab data and poison control records link the compound to headaches, vomiting, cardiac issues, and kidney damage after exposure. According to the Centers for Disease Control and Prevention, both antimony and tartaric acid each bring their own toxicity. Together, risk runs higher–even small amounts can upset a healthy system.
Most folks run into potassium antimonyl tartrate in chemistry settings, not down at the corner store. Chemists know the drill: gloves, eye protection, lab coats. Some workplaces go a step further with full respirators and containment hoods. Dust from this powder travels in the air and can enter lungs. Accidental splashes target eyes or hands. Whether inhaled, swallowed, or absorbed through skin, symptoms show up. Medical literature logged cases of vomiting, diarrhea, and even heart rhythm changes among workers and patients.
Generations back, chemical safety meant learning from mistakes. Now, years of data and workplace accidents turned into regulation. The Occupational Safety and Health Administration (OSHA) spells out exposure limits for antimony. Material safety data sheets warn about cancer, organ damage, and the countless ways chemicals sneak into the body. Folks handling these substances recognize the tough balance: advances in science and health only come with strict respect for what can go wrong.
Avoiding problems with potassium antimonyl tartrate usually means using less hazardous alternatives whenever possible. Many industries phased out heavy-metal reagents for cleaner, greener chemistry. Some of the best solutions draw from transparency and education. Regular training sessions—practical, hands-on instruction—help everyone understand how to spot danger before it starts. Public agencies can do more to spotlight compounds that deserve extra caution. At home, clear labeling puts accidental poisonings at bay.
With any toxic chemical, the smart path relies on staying informed, relying on data, and putting human safety ahead of convenience. Potassium antimonyl tartrate hemihydrate offers a lesson: no shortcut beats respect and care around hazardous materials.
Potassium antimonyl tartrate hemihydrate sits on shelves in many labs and industrial supply rooms, usually as a white crystalline powder. Most folks who come across it know it from chemical tests or research. Some may not realize the real risk hiding in its calm appearance. Years spent working with chemicals have shown me—never judge a compound by its cover. This particular compound reacts badly with air and moisture. If left in the wrong spot, it can clump, break down, or worse, trigger exposure issues. That alone points to the need for good sense storage, both for safety and for the bottom line.
Humidity is a quiet enemy for potassium antimonyl tartrate hemihydrate. This compound doesn't tolerate dampness. I recall a tech who left a jar half open after hurriedly grabbing a sample. By the next shift, the once clear crystals had turned mushy. Product loss like that slows down the pace of science and raises cleanup questions. It does best inside tightly sealed, chemical-resistant containers. Glass or high-density polyethylene work well. A dry area—think low-humidity storage cabinets—gives the best insurance.
Heat shakes up any storage plan. Above-normal temperatures can trigger slow breakdown. For this chemical, even a few degrees up from room temperature begins to matter over time. Don't leave it near radiators, windows with direct sunlight, or microwave ovens in lunchrooms. I’ve seen more than one replacement order go out because someone left the bottle on a bench under a southern window. Middle of the pack temperature, around 15 to 25°C (59-77°F), gives long-term stability without risking crystal structure.
Food and chemicals don’t mix. This basic lab rule protects everyone. Potassium antimonyl tartrate hemihydrate carries toxicity risks no lunchroom should see. Store this compound in dedicated chemical cabinets away from snacks, coffee, or refrigerated food. Labels matter. Each jar or bottle deserves a chemical name, hazard statement, and date received or opened. The most reliable supply rooms I’ve seen post laminated reference sheets near chemicals, showing what each needs to stay safe. Sharp labeling nudges people to remember where sensitive compounds go.
Leaning too much on luck has never helped in chemical storage. Contaminated gloves, accidental spills, and airborne powder can threaten workers. I always reach for gloves and protective eyewear, even if a task seems quick. Storing potassium antimonyl tartrate hemihydrate away from acids and strong oxidizers adds another layer of safety. Chemical shelves packed tight with incompatible materials invite disaster—a lesson learned the hard way in older school labs. A little elbow room and careful planning pay off.
Storage habits drift over years, especially as faces change in a workplace. A routine check—every six months or so—helps spot leaks, broken seals, or fading labels. I make time for these walk-throughs, even if the to-do list feels endless. These quick audits preserve product value and reduce emergencies. Sharing tips between shifts or at team meetings keeps good ideas alive, especially if new staff join who never learned the “whys” of safe storage.
Simple steps—airtight containers, dry space, correct temperature, proper signage, dedicated cabinets—lower risk and “what now” moments. Buy chemical supplies from reputable sources. Confirm that Safety Data Sheets come with shipments. Create a work culture where everyone takes pride in returned chemicals heading back to the shelf in prime condition. Safe storage supports honest science, fewer health risks, and earns trust in any serious lab.
Potassium antimonyl tartrate hemihydrate crops up in a handful of labs, mostly for chemistry research or sometimes in antimony-based treatments for parasitic infections. If you’ve ever looked at its safety data sheet, it paints a serious picture. This material brings with it both antimony and tartrate hazards. Contact with skin or eyes, inhalation, or accidental swallowing can stir up eye and skin irritation, or worse, toxic reactions. Nobody enjoys hospital trips for something that could have been prevented with a little caution in the lab.
Any time I’ve worked with antimony salts, I suit up as if handling a challenge. Nitrile gloves keep the powder from touching skin. Eyes feel a whole lot safer behind impact-rated goggles, especially since one sneeze could send powder airborne. A long-sleeve lab coat, snapped shut, keeps sleeves and wrists protected. Don’t forget the solid shoes—sandals in a chem lab just invite trouble. When possible, swapping gloves after working with solids and again during clean-up helps cut down on cross-contamination.
Potassium antimonyl tartrate hemihydrate creates fine dust—a real hazard for accidental inhalation. A certified laboratory fume hood solves much of this risk. I always double-check that the sash sits at proper height and air is flowing strong before opening any bottle. If a hood isn’t available, consider the risk: Sometimes it's safer to postpone work until proper ventilation is running. Clean-up becomes important, too. I wet-wipe the work area with damp towels instead of dry cloths, because dust can go airborne again if you swipe it dry. Never reach for a vacuum cleaner not designed for laboratory powders, since regular ones could blow particles out instead of trapping them.
Chemicals like potassium antimonyl tartrate hemihydrate need clear, bold labeling, even if it seems excessive. Misunderstandings about which white powder sits in that bottle are no joke. Store in a tightly sealed container, away from acids or materials that might react. A cool, dry, dedicated cabinet keeps storage simple. Locking the cabinet keeps unauthorized hands and curious students away. I’ve seen close calls in shared labs when labeling gets sloppy or storage containers don’t seal tightly enough. To avoid humidity seeping into containers, include a desiccant pack, especially in muggy climates.
Chemical residues on benches, hands, or lab gear can spark problems long after you’ve finished the work. I keep a dedicated waste container close by, marked for antimony-containing solvents and residues. Washing hands with soap and water goes a lot further than hand sanitizer, which won’t remove dissolved chemicals. Any spill, even a pinch of powder, calls for gloves, wet towels, and proper waste disposal. In the rare case of an incident—goggles splashed or powder inhaled—knowing emergency isolation and eyewash locations helps shave off panicked seconds. It isn’t just about self-protection. Anyone else entering that workspace deserves a safe start as well.
Pretending to know every hazard leads to mistakes. Safety training, sometimes dismissed as repetitive, ends up saving people more times than most realize. Years of lab work taught me that even veterans overlook small steps under pressure. Regular retraining and open discussion with colleagues about safety issues keeps awareness up and mistakes down. If you’re not sure about a chemical, ask—there are no prizes for guessing wrong with something toxic. With careful habits, protective gear, and open communication, potassium antimonyl tartrate hemihydrate remains a research tool and not a health hazard.
| Names | |
| Preferred IUPAC name | potassium;2,3-dihydroxybutanedioate;antimony(3+);hydrate |
| Other names |
Potassium Antimony Tartrate Tartar Emetic Antimony Potassium Tartrate Emetic Tartar Potassium Antimonyl Tartrate Antimonyl Potassium Tartrate Potassium Antimony(III) Tartrate |
| Pronunciation | /poʊˈtæsiəm ænˈtɪməniːl tɑːrˈtreɪt hɛˈmaɪ.haɪdreɪt/ |
| Identifiers | |
| CAS Number | 28300-74-5 |
| Beilstein Reference | 1571438 |
| ChEBI | CHEBI:48630 |
| ChEMBL | CHEMBL1201297 |
| ChemSpider | 15607194 |
| DrugBank | DB11106 |
| ECHA InfoCard | 05fdf25e-57e7-45e9-8afe-28c0d04e2069 |
| EC Number | 206-104-4 |
| Gmelin Reference | 147129 |
| KEGG | C14238 |
| MeSH | D010902 |
| PubChem CID | 24866040 |
| RTECS number | WN6500000 |
| UNII | 9O307K56EI |
| UN number | UN2025 |
| Properties | |
| Chemical formula | K2Sb2(C4H2O6)2·H2O |
| Molar mass | 667.87 g/mol |
| Appearance | White crystalline powder |
| Odor | Odorless |
| Density | 3.367 g/cm³ |
| Solubility in water | Soluble in water |
| log P | -3.18 |
| Vapor pressure | Negligible |
| Acidity (pKa) | 4.2 |
| Basicity (pKb) | 8.2 |
| Magnetic susceptibility (χ) | -65.0e-6 cm³/mol |
| Refractive index (nD) | 1.60 |
| Dipole moment | 0 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 384 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -2003.2 kJ/mol |
| Pharmacology | |
| ATC code | S01AX10 |
| Hazards | |
| Main hazards | Toxic if swallowed, inhaled or in contact with skin; causes damage to organs; may cause respiratory and skin irritation. |
| GHS labelling | GHS05, GHS06, GHS08 |
| Pictograms | GHS06,GHS07 |
| Signal word | Danger |
| Hazard statements | H302: Harmful if swallowed. |
| Precautionary statements | Precautionary statements: P264, P270, P301+P310, P330, P405, P501 |
| NFPA 704 (fire diamond) | 2-2-2-ALK |
| Lethal dose or concentration | LD50 Oral Rat 115 mg/kg |
| LD50 (median dose) | LD50: Oral rat 115 mg/kg |
| NIOSH | TT6300000 |
| PEL (Permissible) | PEL (Permissible Exposure Limit) for Potassium Antimonyl Tartrate Hemihydrate: 0.5 mg/m³ |
| REL (Recommended) | REL: lowest feasible concentration |
| IDLH (Immediate danger) | No IDLH established |
| Related compounds | |
| Related compounds |
Tartar emetic Antimony potassium tartrate Potassium antimony(III) tartrate Potassium antimonyl tartrate Antimonate(III) of potassium Potassium antimonyl tartrate trihydrate |
